Teva Settles With Pfizer Over Xeljanz XR As 2025 Date Looms

Israeli Firm Previously Sued Over Patent Expiring In 2034

 
• By Dean Rudge
  
women's handshake
Teva was sued by Pfizer at the end of 2018 • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products